Work

Pediatric Exclusivity Revenues for Cancer Drugs

Year: 2024

Type: article

Abstract: This cohort study calculates the cost of pediatric trials and the value of pediatric exclusivity for select cancer drugs.

Source: Archives of Pediatrics and Adolescent Medicine

DOI: 10.1001/jamapediatrics.2024.4449

Authors: Ameet Sarpatwari, Liam Bendicksen, Douglas S. Hawkins, Lia Gore, Florence T. Bourgeois

Institutions: Brigham and Women's Hospital, Harvard University, Seattle Children's Hospital, University of Washington, Children's Hospital Colorado, University of Colorado Anschutz, University of Colorado Denver, Boston Children's Hospital, Harvard-MIT Center for Regulatory Science

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4404229353

FWCI: 1.085

Cites: 5

Cited by: 3

Related to: 10